Thyrocare Technologies reported robust Q1 financial results.

Consolidated revenue grew to 240.02 Cr, with profit reaching 51.33 Cr.

The Diagnostic Testing Services segment demonstrated strong performance, and Imaging Services notably turned profitable, signaling operational improvements.